AzPA Pharmacy Flash

• 3-in-1 blood pressure drug may be more effective than current standard care
  A study from the University of South Wales has found that a new triple combination medication, GMRx2, combines low doses of three different anti-hypertensive medications, surpassing a current standard care treatment plan using only one drug.
• After failed FSGS bid, Travere wins full FDA approval for Filspari in IgAN
  The U.S. FDA has approved Travere Therapeutics' Filspari for primary IgA nephropathy, broadening its label and removing a specific urine protein-to-creatinine ratio requirement. The drug slows kidney function decline in adults at risk of disease progression.
• Pharmacists: We must accelerate billing for services
  Pharmacists have been requesting the right to bill major medical insurance companies for their care services for 32 years. However, they are not signing on as covered providers and billing when they have the authority. As of June 2024, 36 states have passed laws mandating coverage and payment for pharmacist services.